Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 709 (USA) (Dr. Novak)
· consented 2012-07-31
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-16 (study day 17.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2012-08-16 (study day 17.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-21 (study day 22.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2012-08-30 (study day 31.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.